Thursday, May 30, 2019

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

from Moneycontrol Business News http://bit.ly/2Kc0mlT

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...